Pay in installments of $5.94 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
47a0f4bc glp1artboard 4 copy 2_108c06e000000000000028.png Realworld impact of adding a glucagonlike peptide1 receptor agonist compared with basal insulin on metabolic targets in adults living with type 2 diabetes and chronic kidney disease already treated with a sodiumglucose What Are GLP 1 Patches? A Helpful Overview Baptist Health Global Gmarket Mobile Replenza debuts nutritional support system for GLP 1 users Tirzepatide Oral Drops VitalCore Health
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.1 ★★★★★
Based on 26 reviews
Sort
Product Reviews
★★★★★ 5
Works great on many different size cans
Works great on various size cans. It is a little larger that other openers, but seems very sturdy. It is a little loud and slow, but not a large concern. Very happy with it.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 18, 2026
★★★★★ 1
Stopped working after 3 months
It stopped working after 3 months.
The motor still runs the gear still turns. But it does not engage the can to cut.
I bought it for a post operative situation and I am glad that it worked when for the length of time it did but it's disappointing that I now have to throw this item away.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 6, 2026
★★★★★ 2
Meh.
Worked great the first couple of times it was used. But then it stopped cutting into the cans and does not open them. It causes the metal to fray off in small pieces which resulted in getting a piece of metal stuck in my finger for weeks so I don't recommend. It's also very loud.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 7, 2026
★★★★★ 5
So simple to use, I'm amazed
Color: Black
Wonderfully helpful. Description is accurate, shipping was quick. I saw a few poor comments, but I have none so far! The can opener has opened cans of several sizes, from tomato paste to large cans of tomatoes; soup cans to strangely shaped. It's opened 30 or so already without loss of power. It's a little noisy, but about equal to that of a stand up opener. It fits in my drawer, which is less deep than most kitchen drawers. Most of all, it's beyond easy to use for arthritic hands. The ONLY CHALLENGE I have is that it sometimes fails to stop when it should. MANUFACTURER: if you read this and have advice, please share.
At this point, I'd say this is a great value for the money.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 18, 2026
★★★★★ 5
Cordless can opener.
Color: Black
Works great and has been very reliable, open many cans on a single charge, would recommend.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 1, 2026
recommand products
Sun Pharma Wins Approval to Launch Generic Wegovy in India Sun Pharmaceutical Industries, India's largest drugmaker by revenue, has received regulatory approval to manufacture and sell a generic version of Novo Nordisk's
22.11
Novo Nordisk's Ozempic® pill, the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes, soon to be available in the US
24.51
is zepbound a tirzepatide or semaglutide A 72-week trial compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% weight loss ✓ Semaglutide:
21.56
Compound Semaglutide
21.03
Zepbound beats Wegovy for weight loss in first head-to-head study
22.44